LDBIO Diagnostics

LDBIO Diagnostics is an independent French company specializing in the development, production, and marketing of in vitro diagnostic tests for parasitology and mycology. Founded in 1998 and headquartered in Lyon, France, the company is renowned for its expertise in confirmatory serological testing, particularly using Western Blot technology with natural antigens.

Core Product Lines

1. Immunoblots (Western Blot Assays):

LDBIO offers a comprehensive range of immunoblot tests designed for the serological confirmation of various parasitic and fungal infections. These tests are particularly useful for confirming positive or equivocal results obtained through initial screening methods. Key assays include:

• Toxo II IgG and IgM for toxoplasmosis
• Aspergillus WB IgG for aspergillosis
• Chagas WB IgG for Chagas disease
• Echinococcus WB IgG for echinococcosis
• Fasciola ES WB IgG for fasciolosis
• Leishmania WB IgG for leishmaniasis
• Schisto II WB IgG for schistosomiasis
• Toxocara WB IgG for toxocariasis
• Trichinella ES WB IgG for trichinellosis

These immunoblots are available in various kit sizes to accommodate different laboratory needs.

2. Rapid Tests (Immunochromatographic Tests - ICT):

Designed for point-of-care settings, LDBIO's rapid tests provide quick and reliable results for the detection of specific IgG and IgM antibodies. Notable tests include:

• Toxoplasma ICT IgG-IgM
• Aspergillus ICT IgG-IgM
• Schistosoma ICT IgG-IgM
• PEO ICT IgG-IgM for bird-breeder’s lung disease